LORAZEPAM 2 MG/ML ORAL CONCENT
For 30 mL
Pharmacies pay
$20.59 filed
30 × $0.68632 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$28.68 estimated
$20.59 + $3.09 (15%) + $5.00 fee per fill = $28.68
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
LORAZEPAM 2 MG/ML ORAL CONCENT is how the CMS NADAC file names this product. The FDA NDC Directory lists it as lorazepam.
FDA gives its dosage form as “liquid” and “concentrate” and its route as oral.
Its labelers, the companies named on the label, are Pharmaceutical Associates, Inc., Chartwell RX, LLC and Amneal Pharmaceuticals LLC.
FDA’s Established Pharmacologic Class for it is Benzodiazepine.
The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $20.59 for 30 mL (30 × $0.68632 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.
What NADAC measures · NADAC explanation codes
All 3 NDCs
- 00121-0770-01 · Pharmaceutical Associates, Inc. · $0.68632 per ML · eff. 2026-09-23 filed
- 62135-0549-43 · Chartwell RX, LLC · $0.68632 per ML · eff. 2026-09-23 filed
- 65162-0687-84 · Amneal Pharmaceuticals LLC · $0.68632 per ML · eff. 2026-09-23 filed
Other strengths, forms and brands
9 other products in the NADAC file share the FDA nonproprietary name lorazepam with LORAZEPAM 2 MG/ML ORAL CONCENT.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| LORAZEPAM 0.5 MG TABLET | $0.03443 per EA filed | We don’t know yet |
| LORAZEPAM 1 MG TABLET | $0.03671 per EA filed | We don’t know yet |
| LORAZEPAM 2 MG TABLET | $0.07314 per EA filed | We don’t know yet |
| LORAZEPAM 2 MG/ML ORAL CONCENT this page | $0.68632 per ML filed | We don’t know yet |
| LORAZEPAM 2 MG/ML VIAL | $2.17153 per ML filed | $2.197 per ML derived |
| LORAZEPAM INTENSOL 2 MG/ML | $0.68632 per ML filed | We don’t know yet |
| LOREEV XR 1 MG CAPSULE | $14.20977 per EA filed | $14.6965 per EA filed |
| LOREEV XR 1.5 MG CAPSULE | $14.24867 per EA filed | $14.6965 per EA filed |
| LOREEV XR 2 MG CAPSULE | $14.19082 per EA filed | $14.6965 per EA filed |
| LOREEV XR 3 MG CAPSULE | $14.22681 per EA filed | $14.6965 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
Compared with its class
The middle of its 3 NDCs’ NADAC prices is $0.68632 per ML filed.
Of the 13 other products in FDA’s Benzodiazepine class priced per ML, 6 have a higher middle NADAC price and 6 a lower one; 1 has the same. The one in the middle is LORAZEPAM INTENSOL 2 MG/ML, at $0.68632 per ML filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 mL? Is it lower than what I would pay through my insurance?
- How much is in the package I am getting? This page uses 30 mL; your package may hold a different amount.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why does this page start at 30 mL?
- NADAC prices this product per ML. The FDA NDC Directory’s package description gives 30 mL in one package for all 3 NDCs of this product (“1 BOTTLE, DROPPER in 1 CARTON (0121-0770-01) / 30 mL in 1 BOTTLE, DROPPER”), so the card starts at one package: 30 ML. Change it to match your prescription.
Related pages
Its pharmacologic class
Related in the same class
- ALPRAZOLAM 0.25 MG TABLET
- CLONAZEPAM 0.5 MG TABLET
- DIAZEPAM 10 MG TABLET
- TEMAZEPAM 15 MG CAPSULE
- CLORAZEPATE 15 MG TABLET